More isn't better particularly with vitamin A, iron, and combination "fertility blends"
#Semaglutide #PatentExpiry #PharmaIndustry #DiabetesCare #GLP1 #HealthcareAccess To view or add a comment, sign in Big Update for Healthcare in India Semaglutide Patent Expiry (March-2026) One of the most significant upcoming patent expiries is Semaglutide, a blockbuster drug widely used for Type-2 Diabetes and Obesity (brands such as Ozempic and Wegovy)
The table calls intermittent fasting of roughly 12 to 16 hours generally more compatible, since shorter windows align with reduced appetite
Plasma visfatin levels and gene expression in morbidly obese women with associated fatty liver disease
IV is preferred due to variable oral bioavailability (discussed further below)
The strategy of repurposing medications for new uses is not only a promising approach for modern medicine, but also supports the validity of the integrative physiological approach to evaluating the overall health of an individual